News

Major Step Forward for First Busey and CrossFirst Merger Plans

Major Step Forward for First Busey and CrossFirst Merger Plans

First Busey and CrossFirst Announce Shareholder Approval

In a significant step forward, First Busey Corporation (NASDAQ: BUSE) and CrossFirst Bankshares, Inc. (NASDAQ: CFB) have reported that their respective shareholders have approved the merger agreement, signaling strong support for this transformative partnership. The special meetings for shareholder voting took place recently, and the outcomes reflect the confidence that both parties have in their strategic direction.

The Significance of Shareholder Approval

Van Dukeman, Chairman and CEO of First Busey, expressed his satisfaction with the overwhelming approval and highlighted it as a crucial milestone in their merger journey. This vote showcases shareholders' belief in the unique value this merger presents, which is anticipated to foster growth and create substantial benefits for associates, clients, and the communities they serve.

Now that the shareholder approvals are in place, the companies are moving forward to secure necessary regulatory clearances, which are vital for closing the deal. Both organizations are optimistic that the merger will be finalized within the first or second quarter of 2025, subject to the usual closing conditions.

Future Prospects for Combined Operations

Mike Maddox, CEO of CrossFirst, echoed similar sentiments, expressing confidence in the merger's strategic advantages. This collaboration will culminate in a commercial banking entity equipped to operate from 77 locations across multiple states, boasting combined assets of nearly $20 billion. The proposed union will also enhance the deposits, loans, and wealth management services available to all clients.

With a shared commitment to serving their customers, both banks plan to leverage their compatible banking philosophies and operational strengths to optimize performance metrics significantly. This merger is expected to lead to improvements in net interest margins and operational efficiency.

Overview of First Busey Corporation

Established as a robust financial entity, First Busey Corporation operates from its headquarters in Champaign, Illinois. As of the latest financial reports, First Busey holds assets reaching $11.99 billion, with its banking subsidiary, Busey Bank, accounting for a significant portion of this figure. Busey Bank prides itself on a network of 62 banking centers across various markets, providing a wide range of services designed to meet individual and business banking needs.

Beyond traditional banking, Busey is recognized for its comprehensive Wealth Management division. With $13.69 billion in assets under stewardship, this division offers wealth advisory services to a diverse clientele, ensuring tailored solutions that enhance financial well-being.

The Role of CrossFirst Bankshares

CrossFirst Bankshares, based in Leawood, Kansas, is also a formidable player in the financial services sector. The bank focuses on serving businesses and individuals through personalized banking solutions. CrossFirst is committed to building strong relationships with clients, which it views as fundamental to its success. The shared mission of providing exceptional service aligns seamlessly with First Busey’s ethos.

As both institutions pave the way forward, they look to capitalize on their blending of strengths to create a premier financial institution positioned for future growth. The combined bank is set to gain an expansive footprint in the marketplace, allowing it to capture a greater share of customer needs.

Recognitions and Achievements

Both First Busey and CrossFirst have received accolades for their customer service and operational excellence. Notably, Busey Bank was recognized among the World’s Best Banks and the Best Banks to Work For, highlighting its strong workplace culture and commitment to community development. These honors underscore the dedication both companies have towards ensuring a positive impact on clients and the industry at large.

Frequently Asked Questions

What does the merger between First Busey and CrossFirst entail?

The merger intends to combine resources and create a full-service commercial bank with a broader range of financial services across multiple states.

How will shareholder approval impact the merger timeline?

Shareholder approval is crucial as it allows the companies to proceed with getting necessary regulatory approvals before finalizing the merger, expected in early 2025.

What benefits will arise from the merger for customers?

The merger aims to enhance service offerings, increase asset management capabilities, and provide access to a wider range of financial products.

Where will the new joint banking entity operate?

The newly formed bank will operate from 77 locations across several states, combining strengths and capabilities of both institutions.

How will the merger affect employees of both banks?

While specific impacts on employees are still being assessed, the focus is on maintaining key personnel and fostering a collaborative workplace culture for all associates.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Vipshop Prepares for Q3 Financial Results Release

Updated Category News Views 60

Countdown to Vipshop's Third Quarter Results November 24th might just be another day on the calendar for some, but for those of us keeping tabs on the markets, it's a make-or-break moment for Vipshop Holdings Limited. The off-price retail titan from China, trailing under the ticker NYSE:VIPS, is gearing up to swing the doors wide open on its third-quarter financial...

Continue Reading
Orangetheory Adds NASM Training for Coaching Edge

Updated Category News Views 19

A Shift in Coaching Standards Ever seen a fitness brand tilt towards a change so fast it leaves you slack-jawed? Well, here we go with Orangetheory Fitness pushing its chips all in with NASM-certified coaches geared for the GLP-1 era. A bold move? Sure, but they aim to become trendsetters instead of just another player in the fitness game. The Impact of NASM Certification...

Continue Reading
HearUSA Expands Access with AI-Powered Hearing Aids

Updated Category News Views 24

AI Revolution in Hearing Care Look, the hearing aid industry isn't known for headlines that grab you by the throat, but HearUSA just tossed a proverbial grenade into the scene with Widex Allure AI RIC. This is more than a slight tweak in hearing tech—it's a game-changer. We're talking about on-demand AI noise management blended with Widex's renowned natural sound. It's...

Continue Reading
Akeso's Gumokimab Wins NMPA Approval for AS Treatment

Updated Category News Views 139

Gumokimab Approved: A New Dawn in AS Treatment Yeah, the biotech world shifts gears today as Akeso's gumokimab received the green light from China's National Medical Products Administration (NMPA). This approval for treating ankylosing spondylitis, or AS, isn't just another checkbox for Akeso; it's a game-changer in tackling this chronic inflammatory disease. Why should...

Continue Reading
YYForce's Strategic Play: Robotics and AI Expansion

Updated Category News Views 11

Innovation Meets Pragmatism at YYForce There's a new bout of excitement brewing over at YYForce Inc. (NASDAQ: YFOR), if the latest announcements are anything to go by. The Singapore-based AI-enabled workforce dynamo is laying out priorities like a general plotting a campaign—pragmatic, strategic, and with a keen eye on the bottom line. Aiming for a Technological Edge In...

Continue Reading
Flagship's £100M London Move to Ignite AI Ventures

Updated Category News Views 150

London Calling: Flagship's New Venture Flagship Pioneering, the brain behind bustling biotech ventures like Moderna, is planting its flag in London. They're launching Flagship Origination Lab, U.K., their first real gig outside good ol' Cambridge, Massachusetts. They're diving in headfirst, sprinkling a whopping £100 million to brew up AI-native platform companies. And...

Continue Reading
YONDELIS: Thai Approval Opens New Sarcoma Treatment Path

Updated Category News Views 254

New Hope for Thai Sarcoma Patients Alright, we’ve got some good news coming out of Thailand, folks. The Thai FDA just greenlit YONDELIS® (trabectedin) for those grappling with advanced soft tissue sarcoma (STS). Now, this isn’t your everyday drug release—it’s a clinical chess move packing potential for patients who’ve run out of other options. December 1st,...

Continue Reading
CureGene's CG-0416: Promising Weight Loss Breakthrough

Updated Category News Views 94

Game-Changer in Weight Management? Oh, the obesity world is buzzing, folks! There's some big noise coming from CureGene, and it's catching the attention of every lab-coat smarty in town. They just tossed out some preclinical data on CG-0416 at Obesity Week 2026 that could shake up how we tackle weight loss. Anyone still clinging to their old diet books might want to take...

Continue Reading
Asia-Pacific Miracle: New Economic Chapter Unfolds

Updated Category News Views 31

A Fresh Breeze in Asia-Pacific's Sails You ever look around and realize everything's about to change—again? That's Asia-Pacific right now. We're staring down the barrel of a new chapter in what folks are calling the "Asia-Pacific miracle." The text from China Daily paints a picture of a region gearing up to crank the cooperation dial even higher. And where's this...

Continue Reading
Portillo's Faces Class Action: Investor Losses at Stake

Updated Category News Views 343

Investor Tensions Rise as Portillo's Inc. Lawsuit Unfolds Investment ain't all sunshine and rainbows, and if you've been holding Portillo's Inc. (NASDAQ: PTLO) stocks between September 19, 2023, and May 4, 2026, you might find yourself caught in a storm front. We're talking shareholder class action lawsuit, folks, thanks to some allegedly misguided management moves. This...

Continue Reading

Top 5 Most Recently Viewed Articles

BitGo Faces Securities Fraud Suit Amid Investor Losses

Updated Category News Views 69

BitGo's Legal Woes: A Deep Dive into the Allegations A lawsuit can shake up a company's foundations, and BitGo Holdings, Inc. (NYSE: BTGO) is feeling the heat right now. The focus of this busy investor morning isn’t some penny stock drama; we're talking about players in the digital asset game accused of pulling the wool over investors' eyes. Slap on those reading...

Continue Reading
Investors Alert: Deadline Approaches in Match Group Lawsuit

Updated Category News Views 141

Important Deadline Approaching for Match Group Investors Recently, there has been a notable reminder for investors concerning a class action lawsuit involving Match Group, Inc. (NASDAQ: MTCH). The law firm Glancy Prongay & Murray LLP has highlighted that all individuals who purchased shares in Match Group during the specified period should be aware of the upcoming...

Continue Reading
Leadership Transition at Coloplast A/S: New Era Begins

Updated Category News Views 937

Coloplast A/S Announces Leadership Change In a significant shift for Coloplast A/S, CEO Kristian Villumsen has officially stepped down. Today marks the start of a new chapter as the Board of Directors mobilizes Lars Rasmussen to serve as interim CEO while the search for a permanent replacement is conducted. Strategic Shift for the Future This change comes at an opportune...

Continue Reading
Johnson & Johnson's Strong Q3 Results Amid Market Declines

Updated Category News Views 109

Market Overview On a day marked by declining values, U.S. stocks experienced a noticeable downturn. The Nasdaq Composite index saw a drop of around 150 points, indicating a challenging market environment. As trading progressed, the Dow Jones Industrial Average slipped slightly, and the S&P 500 also followed suit, showing varied performance across sectors. Sector...

Continue Reading
Moroccanoil Expands Product Line at Ulta Beauty Nationwide

Updated Category News Views 204

Moroccanoil Expands Product Line at Ulta Beauty Nationwide Moroccanoil is thrilled to announce an exciting partnership with Ulta Beauty, the premier beauty retailer in the nation. This significant expansion reaffirms Moroccanoil's commitment to delivering high-quality beauty products to a wider audience while honoring its legacy rooted in the salon community. Launching at...

Continue Reading